Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study

Eur Heart J. 2024 Nov 20:ehae781. doi: 10.1093/eurheartj/ehae781. Online ahead of print.
No abstract available

Keywords: Atherosclerotic cardiovascular disease; Clinical trial; Lipoprotein(a).

Grants and funding